Dyadic announces research, license and collaboration for the manufacture of animal free ingredients

Jupiter, fla., may 11, 2022 (globe newswire) -- dyadic international, inc. (“dyadic”, “we”, “us”, “our”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on further improving, applying, and deploying its proprietary protein production platform, today announced that it has entered into a joint development agreement (“agreement”) with a global food ingredients company to develop and manufacture a number of animal free ingredient products using the company's biotechnologies.
DYAI Ratings Summary
DYAI Quant Ranking